ArticleFrontiers in nutrition2025
Association between dietary niacin intake and mortality among US individuals with chronic obstructive pulmonary disease: data from the national health and nutrition examination survey 1999-2018.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anemia and hemoglobin thresholds of 12.5 and 13.0 g/dL are associated with distinct cardiovascular and all-cause mortality risks in COPD.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Chronic obstructive pulmonary disease (COPD) is a long-lasting condition that significantly hinders respiratory function. Niacin, a crucial nutrient in the diet, is essential for maintaining general health. However, research on the effects of niacin on the mortality risk among individuals with COPD is sparse. Hence, this study aims to investigate the relationship between dietary niacin intake and mortality within this specific cohort of individuals. Methods and results: A total of 3,674 self-reported COPD individuals from the National Health and Nutrition Examination Survey (NHANES) 1999-2018 were included in this study. The Cox proportional hazards model assessed the association between niacin intake and all-cause/cardiovascular disease (CVD) mortality. Kaplan-Meier curves illustrated survival based on niacin intake. Subgroup and sensitivity analyses were conducted to assess the robustness of the results. During an average follow-up period of 8.3 years, 1,085 all-cause deaths occurred, including 323 CVD-related deaths. A 10 mg/day niacin increase was associated with a 12% lower all-cause and 13% lower CVD mortality risk. Compared to the low dietary niacin intake group, the high intake group had a hazard ratio (HR) of 0.67 (95% CI: 0.56-0.82, Conclusion: A higher dietary intake of niacin was associated with lower all-cause and CVD mortality among individuals with COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.